{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03298802",
            "orgStudyIdInfo": {
                "id": "16-0280"
            },
            "organization": {
                "fullName": "The University of Texas Medical Branch, Galveston",
                "class": "OTHER"
            },
            "briefTitle": "Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide",
            "officialTitle": "Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide: a Randomized Clinical Trial",
            "therapeuticArea": [
                "Cardiovascular",
                "Other"
            ],
            "study": "postpartum-management-of-hypertension-in-pregnancy-with-hydrochlorothiazide"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2017-11-21",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-08-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-08-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2017-09-20",
            "studyFirstSubmitQcDate": "2017-09-29",
            "studyFirstPostDateStruct": {
                "date": "2017-10-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-01",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "The University of Texas Medical Branch, Galveston",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.",
            "detailedDescription": "To evaluate effectiveness of hydrochlorothiazide prophylaxis on prophylaxis, prevention and relapse of preeclampsia or gestational hypertension on readmission rates, need for additional antihypertensive therapy and number of triage visits."
        },
        "conditionsModule": {
            "conditions": [
                "Pre-Eclampsia",
                "Gestational Hypertension",
                "Superimposed Pre-Eclampsia",
                "Hypertension, Pregnancy-Induced",
                "Postpartum Pregnancy-Induced Hypertension",
                "Postpartum Preeclampsia"
            ],
            "keywords": [
                "readmission",
                "triage visit for pregnancy related hypertension",
                "hydrochlorothiazide"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "double-blind randomized placebo controlled clinical trial",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "maskingDescription": "Randomization will be performed by a person not involved in the clinical trial using a computer random list of numbers generated using STATA (StataCorp 14.0, Dallas, TX). This list of random number assignments will be kept secure and sent directly to the investigational drug service (IDS), who will be responsible for the allocation and dispensing of the medications",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 612,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Hydrochlorothiazide 50mg Tablet",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Hydrochlorothiazide 50 mg per os once daily as soon as the subjects can tolerate sips of water after delivery and for a total of fourteen days postpartum.",
                    "interventionNames": [
                        "Drug: Hydrochlorothiazide 50mg Tablet"
                    ]
                },
                {
                    "label": "Placebo Tablet",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo per os once daily as soon as the subjects can tolerate sips of water after delivery and for fourteen days postpartum",
                    "interventionNames": [
                        "Drug: Placebo Tablet"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Hydrochlorothiazide 50mg Tablet",
                    "description": "Hydrochlorothiazide 50 mg per os once daily as soon as the subjects can tolerate sips of water after delivery and for a total of fourteen days postpartum.",
                    "armGroupLabels": [
                        "Hydrochlorothiazide 50mg Tablet"
                    ],
                    "otherNames": [
                        "HydroDIURIL, Microzide, Esidrix, Oretic"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo Tablet",
                    "description": "Placebo per os once daily as soon as the subjects can tolerate sips of water after delivery and for a total of fourteen days postpartum",
                    "armGroupLabels": [
                        "Placebo Tablet"
                    ],
                    "otherNames": [
                        "sugar pill"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Rate of readmission and/or triage visits",
                    "description": "Any visit in the hospital",
                    "timeFrame": "1-6 weeks postpartum"
                },
                {
                    "measure": "Need for additional antihypertensive therapy",
                    "description": "Requiring additional antihypertensive agents in the postpartum period",
                    "timeFrame": "1-6 weeks postpartum"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Length of hospital stay",
                    "description": "Days that patient required to be in-house in the postpartum period",
                    "timeFrame": "1-6 weeks postpartum"
                },
                {
                    "measure": "Total Additional doses of anti-hypertensive therapy",
                    "description": "Addition of total doses that patient received in the postpartum period",
                    "timeFrame": "1-6 weeks postpartum"
                },
                {
                    "measure": "Elevation of blood pressure >150/90",
                    "description": "Hypertension definition in the postpartum period",
                    "timeFrame": "1-6 weeks postpartum"
                },
                {
                    "measure": "Severe composite maternal morbidity",
                    "description": "o Any of the following: ICU admission, HELLP syndrome, eclampsia, stroke, renal failure, pulmonary edema, cardiomyopathy or maternal death",
                    "timeFrame": "1-6 weeks postpartum"
                },
                {
                    "measure": "Use of resources",
                    "description": "hospital stay, postpartum clinic or emergency room visit within 4-6 weeks of delivery, need for imaging or other invasive procedures.",
                    "timeFrame": "1-6 weeks postpartum"
                },
                {
                    "measure": "Adverse Events",
                    "description": "Allergic reactions (anaphylaxis, angioedema, skin rashes including Stevens Johnson and Toxic Epidermal necrolysis)",
                    "timeFrame": "1-6 weeks Postpartum"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Maternal age \u2265 18 years and \\<50 years.\n* Diagnosis of gestational hypertension\\* or preeclampsia\\^ at any time during pregnancy, labor or postpartum.\n\n  * defined as isolated systolic BP of 140 mm Hg or greater, a diastolic BP of 90 mm Hg or greater, or both) or \\^ defines as new-onset hypertension plus new-onset proteinuria, or in the absence of proteinuria, preeclampsia is diagnosed as hypertension in association with thrombocytopenia (platelet count less than 100,000/microliter), impaired liver function (elevated blood levels of liver transaminases to twice the normal concentration), the new development of renal insufficiency (elevated serum creatinine greater than 1.1 mg/dL or a doubling of serum creatinine in the absence of other renal disease), pulmonary edema, or new-onset cerebral or visual disturbances.)\n\nExclusion Criteria:\n\n* Subject requiring antihypertensive therapy at time of screening.\n* Planned discharge with oral anti-hypertensive medication.\n* Contraindication to hydrochlorothiazide (advanced renal failure or anuria, hypersensitivity to sulfonamides).\n* Subject not able to follow up postpartum.\n* Lactose intolerance.\n* Pre-gestational diabetes.",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "genderBased": true,
            "genderDescription": "Women after delivery of neonate",
            "minimumAge": "18 Years",
            "maximumAge": "50 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Megan C Shepherd, M.D.",
                    "role": "CONTACT",
                    "phone": "409-772-0312",
                    "email": "mcshephe@UTMB.EDU"
                },
                {
                    "name": "Ashley Salazar, RN",
                    "role": "CONTACT",
                    "phone": "409-772-0312",
                    "email": "assalaza@utmb.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Benjamin Bush, M.D.",
                    "affiliation": "UTMB",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "St. David's North Austin Medical Center",
                    "status": "RECRUITING",
                    "city": "Austin",
                    "state": "Texas",
                    "zip": "78758",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Caroline Gleason, RN",
                            "role": "CONTACT",
                            "phone": "512-821-2540",
                            "email": "Caroline.Gleason@hcahealthcare.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.26715,
                        "lon": -97.74306
                    }
                },
                {
                    "facility": "University of Texas Medical Branch",
                    "status": "RECRUITING",
                    "city": "Galveston",
                    "state": "Texas",
                    "zip": "77555",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Benjamin Bush, MD",
                            "role": "CONTACT",
                            "phone": "409-772-1011",
                            "email": "babush@utmb.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.30135,
                        "lon": -94.7977
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011225",
                    "term": "Pre-Eclampsia"
                },
                {
                    "id": "D000004461",
                    "term": "Eclampsia"
                },
                {
                    "id": "D000046110",
                    "term": "Hypertension, Pregnancy-Induced"
                },
                {
                    "id": "D000006973",
                    "term": "Hypertension"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000011248",
                    "term": "Pregnancy Complications"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "asFound": "Hypertension",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7633",
                    "name": "Eclampsia",
                    "asFound": "Eclampsia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14106",
                    "name": "Pre-Eclampsia",
                    "asFound": "Pre-Eclampsia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25635",
                    "name": "Hypertension, Pregnancy-Induced",
                    "asFound": "Hypertension, Pregnancy-Induced",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "T2019",
                    "name": "Eclampsia",
                    "asFound": "Eclampsia",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006852",
                    "term": "Hydrochlorothiazide"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000959",
                    "term": "Antihypertensive Agents"
                },
                {
                    "id": "D000004232",
                    "term": "Diuretics"
                },
                {
                    "id": "D000045283",
                    "term": "Natriuretic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000049993",
                    "term": "Sodium Chloride Symporter Inhibitors"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9910",
                    "name": "Hydrochlorothiazide",
                    "asFound": "White",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4277",
                    "name": "Antihypertensive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7411",
                    "name": "Diuretics",
                    "relevance": "LOW"
                },
                {
                    "id": "M26152",
                    "name": "Sodium Chloride Symporter Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AnAg",
                    "name": "Antihypertensive Agents"
                },
                {
                    "abbrev": "NaAg",
                    "name": "Natriuretic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}